What does CUSIP 98420N105 represent in this 13F holders report?

CUSIP 98420N105 is the security identifier for XENE - Xenon Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held XENE - Xenon Pharmaceuticals Inc. - Common Stock in Q4 2023?

204 institutional investors reported XENE - Xenon Pharmaceuticals Inc. - Common Stock for Q4 2023. Use the holders table for investor-level position and value details.

Xenon Pharmaceuticals Inc. - Common Stock (XENE)

CUSIP: 98420N105

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Common Stock
Total 13F shares: 72,058,517
Total 13F value: $3,319,081,625
Share change: +9,933,060
Put/Call ratio: 81%
SEC-reported price per share: $46.06
Number of holders: 204
Value change: +$473,994,183
Number of buys: 124
Number of sells: 72
Shares outstanding: 95,032,800

Security key

98420N105

Report period

Q4 2023

Institutions

204

Top holders

XENE full security history Ownership snapshot Full 13F holder table Xenon Pharmaceuticals Inc. SEC filings Xenon Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Avoro Capital Advisors LLC

Disclosed value leader

Avoro Capital Advisors LLC

Comparable rows

15/15

Latest evidence

30 Sep 2023

13F Lead comparable stake: 5.2% Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 5.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.

Comparable ownership Top 5

Avoro Capital Advisors LLC 5.2%

DRIEHAUS CAPITAL MANAGEMENT LLC 4.7%

FMR LLC 4.5%

Polar Capital Holdings Plc 3.2%

Capital International Investors 2.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Avoro Capital Advisors LLC	13F Company 13F	5.2%	$167,384,000 4,900,000 shares	—	30 Sep 2023
DRIEHAUS CAPITAL MANAGEMENT LLC	13F Company 13F	4.7%	$154,164,251 4,513,005 shares	—	30 Sep 2023
FMR LLC	13F Company 13F	4.5%	$145,277,903 4,252,866 shares	—	30 Sep 2023
Polar Capital Holdings Plc	13F Company 13F	3.2%	$102,607,998 3,003,747 shares	—	30 Sep 2023
Capital International Investors	13F Company 13F	2.6%	$83,583,371 2,446,820 shares	—	30 Sep 2023
Capital World Investors	13F Company 13F	2.4%	$77,713,112 2,274,974 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

204

72,058,517

Rows available

204

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

180

Q4 2023 holders

204

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %